SCHEMBL2929023

SCHEMBL2929023

O=Cc1cn(C(=O)OCc2ccc([N+](=O)[O-])cc2)c(-c2nccs2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ GAA P10253 3/20 0.37
▸ NPC1 O15118 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ POLB P06746 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ LMNA P02545 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MGAM O43451 2/20 0.35
▸ SI P14410 2/20 0.35
▸ MGAM2 Q2M2H8 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ STAT1 P42224 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ CCR3 P51677 1/20 0.35
▸ MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2927815 0.81 RAB9A (0.42) RAB9AL3MBTL1MEN1KMT2APOLB
SCHEMBL2928232 0.75 RAB9A (0.42) RAB9AL3MBTL1NPC1MEN1KMT2A
SCHEMBL2928341 0.69 ALDH1A1 (0.42) RAB9AMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL3072972 0.65 PDPK1 (0.53) RAB9AGAANPC1MEN1KMT2A
SCHEMBL20919972 0.64 ALDH1A1 (0.54) RAB9AL3MBTL1MEN1KMT2ALMNA
SCHEMBL2047421 0.63 PDE10A (0.44) RAB9ANPC1RECQL
SCHEMBL5505388 0.63 XDH (0.48) RAB9AGAANPC1MEN1KMT2A
SCHEMBL9185772 0.63 IDO1 (0.54) RAB9ANPC1SMN1; SMN2LMNAMAPT
SCHEMBL11687557 0.62 SMN1; SMN2 (0.57) RAB9AL3MBTL1NPC1MEN1KMT2A
SCHEMBL4470296 0.62 ALDH1A1 (0.48) RAB9AMEN1KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499620-B1 PROCESS FOR PREPARING 6-ALKYLIDENE PENEM DERIVATIVES WYETH CORP (US) 2010-01-27 — — EP disclosed
EP-1499620-A1 PROCESS FOR PREPARING 6-ALKYLIDENE PENEM DERIVATIVES Wyeth (US) 2005-01-26 — — EP disclosed
US-20040132708-A1 Process for preparing 6-alkylidene penem derivatives WYETH 2004-07-08 — — US disclosed
US-20040053913-A1 Process for preparing 6-alkylidene penem derivatives WYETH 2004-03-18 — — US disclosed
WO-2003093277-A1 PROCESS FOR PREPARING 6-ALKYLIDENE PENEM DERIVATIVES WYETH (US) 2003-11-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132708-A1 Process for preparing 6-alkylidene penem derivatives PGM2, BPGM, MRPL21 RAB9A 1712/4885L3MBTL1 2964/4885GAA 549/4885
US-20040053913-A1 Process for preparing 6-alkylidene penem derivatives PGM2, BPGM, MRPL21 RAB9A 1712/4885L3MBTL1 2964/4885GAA 549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback